Nicholas Hall’s 32nd European CHC Conference took place last week in Athens, and below are the winners of this year’s awards for marketing and innovation in the consumer healthcare industry.
For the Colin Borg European Marketing Award, the top three awarded were as follows:
1st Place: Procto-Glyvenol from Recordati
2nd Place: Otrivin from GSK
3rd Place: Enandol from Menarini
The Winners of the Worldwide Marketing Award were as follows:
1st Place: Xyzal from Sanofi
2nd Place: Eno from GSK
3rd Place: Doril Enxaqueca from Hypera
We finally gave a Special Achievement Award to HRA Pharma (now owned by Perrigo) for Hana, with an honourable mention to Maxwellia’s Lovima, which has the same ingredient as Hana. For this award we celebrated the 360 degree marketing campaign run by HRA for Hana.
Nicholas Hall’s Touchpoints: “The Athens conference … has been a very special meeting; as well as the high level of content and great foresights shared, just to be together as a community will remain fresh in our memories for months and years to come.
The awards we presented this year were particularly welcome as they celebrate achievements made under the extreme circumstances of the pandemic. Not least, we presented a Special Achievement Award for only the 7th time in the almost 35 years of holding events. Three of these awards were given to individuals who made outstanding contributions to the industry, and three to marketers of truly significant new brands. It was in this tradition that we presented the 7th Special Achievement Award to HRA for the launch of Hana, the world’s first OTC daily oral contraceptive supported with 360° marketing support. An honourable mention was given to Maxwellia’s Lovima.
The hope and expectation is that these two new brands will trailblaze a new CHC category, which is vital as our market goes forward. If you look at the DB6 forecasts (see this week’s Dashboard infographic) – growth at 2021 levels is unlikely to be sustained. The only way to put us onto a higher trajectory will be to launch more significant new products and entice increasingly large numbers of consumers to participate in the self-care revolution. Hana is a superb example of how this can be achieved.“
We have now released DB6 forecasts to 2026 & 2031, following the recent publication of our year-end 2021 data. Arrange a demo to take a look for yourself, exploring the expanded channels dataset, which now includes internet & mail order, direct sales and CBD. DB6 offers over 150,000 pieces of data, with more than 30,000 records covering 13,000+ brands and 3,000 companies across 63 countries. To find out more, or to set up a free demo, please contact kate.fieldingsmith@NicholasHall.com.